Description
DC_AC50 is a dual inhibitor of Atox1 and CCS (copper chaperones). Inhibiting intracellular copper chaperones as a means of reducing/preventing acquired chemotherapy resistance. DC_AC50 binding to Atox1 and CCS and reducing cancer cell proliferation and tumour growth